SDEV on NYSE
Stablecoin Development Corp
American finance services company based in Emeryville, incorporated in Delaware. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with Hyperliquid Strategies, Abits Group Inc or POWERCOMPUTE, INC., or pick any stock.
- TickerSDEV on NYSE1
- IndustryFinance Services1
- HeadquartersWest Palm Beach, Florida1
- Incorporated inDE2
- Business address222 Lakeview Ave, Suite 800, West Palm Beach, Fl 334012
- Filer categoryNon-accelerated filer, Smaller reporting company2
- Legal formCorporation
See how the biggest companies compare on our leaderboards
We have undergone significant changes to our business and operations as a result of a series of completed transactions summarized below and discussed in further detail under the next section titled “Recent Developments” below. As a result of these transactions, we have significantly reduced our legacy pharmaceutical business operations and have adopted a new strategic direction as a business, shifting to a capital allocation strategy that focuses on acquiring digital assets that provide exposure to economic participation within open digital financial networks.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2024
Where the money goes
Where each dollar of revenue went, fiscal 2024
- Cost of revenue34¢$3.3M
- Research and development0¢$42.0K
- Other costs66¢$6.4M
Out of $9.8M in revenue.45 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| General and administrative | $7.6M | $7.4M |
| Impairment of long-lived assets | $854.0K | $0 |
| Total operating expenses | $8.4M | $7.4M |
| Operating loss | -$8.4M | -$7.4M |
| Non-cash (loss) gain on changes in fair value of warrant liability | -$509.9M | $114.0K |
| Non-cash loss on fair value of warrant liability in excess of proceeds at issuance | -$123.2M | $0 |
| Accretion of interest and amortization of discounts on convertible notes | -$277.0K | -$904.0K |
| Other expense, net | -$20.0K | -$581.0K |
| Net loss from continuing operations | -$641.9M | -$8.8M |
| Net income from discontinued operations, net of taxes | $11.1M | $1.5M |
| Net loss | -$630.8M | -$7.2M |
| Less: Increase to accumulated deficit due to adjustment to common stock warrant exercise price | $0 | -$1.0M |
| Less: Increase to accumulated deficit due to adjustment to Preferred Stock conversion price | $0 | -$380.0K |
| Net loss attributable to common stockholders | -$630.8M | -$8.6M |
| Basic (and diluted for net loss) (in shares) | 5.8M shares | 679.0K shares |
| Basic loss per share from continuing operations (in dollars per share) | -$110 | -$15 |
| Basic earnings per share from discontinued operations (in dollars per share) | $2 | $2 |
| Basic (loss) earnings per share attributable to common stockholders (in dollars per share) | -$108.39 | -$12.68 |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $8.0M | $430.0K | |
| Prepaid expenses and other current assets | $717.0K | $272.0K | |
| Current assets, discontinued operations | $0 | $1.2M | |
| Total current assets | $8.7M | $1.9M | |
| Operating lease right-of-use assets | $0 | $955.0K | |
| Other assets | $360.0K | $524.0K | |
| Other assets, discontinued operations | $0 | $9.0K | |
| TOTAL ASSETS | $9.0M | $3.4M | |
| Accounts payable | $257.0K | $109.0K | |
| Accrued liabilities | $396.0K | $581.0K | |
| Bridge Loan | $0 | $500.0K | |
| Unsecured Convertible Notes, net of discounts | $67.0K | $65.0K | |
| Operating lease liabilities | $422.0K | $398.0K | |
| Current liabilities, discontinued operations | $0 | $1.2M | |
| Total current liabilities | $1.1M | $2.8M | |
| Warrant liabilities, at fair value | $639.1M | $0 | |
| Operating lease liabilities-non-current | $287.0K | $709.0K | |
| Total liabilities | $640.5M | $3.6M | |
| Additional paid-in capital | $187.0M | $183.3M | |
| Accumulated deficit | -$819.1M | -$183.5M | |
| Total stockholders (deficit) | -$631.8M | -$129.0K | $3.3M |
| TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT | $9.0M | $3.4M | |
| Temporary Equity, Par or Stated Value Per Share (in dollars per share) | $0.01 | $0.01 | |
| Temporary Equity, Shares Authorized (in shares) | 5.0M shares | 5.0M shares | |
| Preferred stock par value (in dollars per share) | $0.01 | $0.01 | |
| Preferred stock, shares authorized (in shares) | 5.0M shares | 5.0M shares | |
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | |
| Common stock, shares authorized (in shares) | 1.5B shares | 1.5B shares | |
| Common stock, shares outstanding (in shares) | 25.2M shares | 977.0K shares | |
| Common stock, shares issued (in shares) | 25.2M shares | 977.0K shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $8.0M | $430.0K | |
| Prepaid expenses and other current assets | $717.0K | $272.0K | |
| Current assets, discontinued operations | $0 | $1.2M | |
| Total current assets | $8.7M | $1.9M | |
| Operating lease right-of-use assets | $0 | $955.0K | |
| Other assets | $360.0K | $524.0K | |
| Other assets, discontinued operations | $0 | $9.0K | |
| TOTAL ASSETS | $9.0M | $3.4M | |
| Accounts payable | $257.0K | $109.0K | |
| Accrued liabilities | $396.0K | $581.0K | |
| Bridge Loan | $0 | $500.0K | |
| Unsecured Convertible Notes, net of discounts | $67.0K | $65.0K | |
| Operating lease liabilities | $422.0K | $398.0K | |
| Current liabilities, discontinued operations | $0 | $1.2M | |
| Total current liabilities | $1.1M | $2.8M | |
| Warrant liabilities, at fair value | $639.1M | $0 | |
| Operating lease liabilities-non-current | $287.0K | $709.0K | |
| Total liabilities | $640.5M | $3.6M | |
| Additional paid-in capital | $187.0M | $183.3M | |
| Accumulated deficit | -$819.1M | -$183.5M | |
| Total stockholders (deficit) | -$631.8M | -$129.0K | $3.3M |
| TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT | $9.0M | $3.4M | |
| Temporary Equity, Par or Stated Value Per Share (in dollars per share) | $0.01 | $0.01 | |
| Temporary Equity, Shares Authorized (in shares) | 5.0M shares | 5.0M shares | |
| Preferred stock par value (in dollars per share) | $0.01 | $0.01 | |
| Preferred stock, shares authorized (in shares) | 5.0M shares | 5.0M shares | |
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | |
| Common stock, shares authorized (in shares) | 1.5B shares | 1.5B shares | |
| Common stock, shares outstanding (in shares) | 25.2M shares | 977.0K shares | |
| Common stock, shares issued (in shares) | 25.2M shares | 977.0K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$630.8M | -$7.2M |
| Net income from discontinued operations, net of taxes | -$11.1M | -$1.5M |
| Stock-based compensation expense related to employee and director stock awards | $29.0K | $148.0K |
| Non-cash loss on extinguishment of Secured Convertible Note | $0 | $13.0K |
| Non-cash expense incurred to obtain consent of Secured Convertible Note holders | $0 | $368.0K |
| Non-cash loss (gain) on changes in fair value of warrant liability | $509.9M | -$114.0K |
| Non-cash loss on fair value of warrant liability in excess of proceeds at issuance | $123.2M | $0 |
| Non-cash loss on changes in fair value of embedded derivative liability | $0 | $18.0K |
| Non-cash loss on modification of warrants | $0 | $69.0K |
| Non-cash right-of-use amortization | $140.0K | $341.0K |
| Impairment of long-lived assets | $854.0K | $0 |
| Amortization of debt discounts on convertible notes | $248.0K | $873.0K |
| Prepaid expenses and other current assets | -$445.0K | -$65.0K |
| Other assets | -$85.0K | $28.0K |
| Accounts payable and accrued liabilities | -$37.0K | -$57.0K |
| Operating lease liabilities | -$398.0K | -$369.0K |
| Net cash used in operating activities, continuing operations | -$8.4M | -$7.5M |
| Proceeds from Warrants Exercise | $852.0K | $247.0K |
| Proceeds from issuance of October 2025 pre-funded warrants | $5.9M | $0 |
| Payment on Bridge Note | -$500.0K | $0 |
| Payments on Secured Convertible Notes | $0 | -$2.0M |
| Payments on warrants purchase | -$2.0M | $0 |
| Dividend paid | -$4.8M | $0 |
| Cash debt issuance cost | $0 | -$115.0K |
| Net cash provided by financing activities, continuing operations | $4.6M | $1.5M |
| Net decrease in cash, cash equivalents, and restricted cash, continuing operations | -$3.8M | -$6.0M |
| Net increase in cash and cash equivalents, discontinued operations | $11.1M | $3.3M |
| Net decrease in cash, cash equivalents and restricted cash, consolidated | $7.3M | -$2.7M |
| Interest paid in continuing operations | $8.0K | $130.0K |
| Conversions of preferred stock to common stock | $5.8M | $1.9M |
| Deemed Capital Contribution pursuant to Series F Agreements | $434.0K | $0 |
| Conversion of Unsecured Convertible Notes to common stock | $246.0K | $0 |
| Down round feature adjustments related to common stock warrants | $0 | $1.0M |
| Down round feature adjustments related to preferred stock | $0 | $380.0K |
| Embedded derivatives, amount reclassified to stockholders' equity | $0 | $242.0K |
| Issuance of derivative liability in conjunction with Unsecured Convertible Notes | $0 | $224.0K |
No quarter-by-quarter statement was filed.
Leadership
Who has led Stablecoin Development Corp, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
- Chief executive officerDavid E. Lazar Aug 26, 2025 to Oct 20, 202513
- Chief executive officerMichael John Kazley Oct 20, 2025 to now14
- Chief executive officerJohn Joseph McGovern Oct 11, 2018 to Oct 11, 201815
- Chief executive officerMark M. Sieczkarek Jun 8, 2016 to Jun 6, 201716
- Chief executive officerRamin Najafi Oct 24, 2007 to Aug 21, 201517
- PresidentJeffrey Kunin Nov 17, 2021 to Dec 7, 202218
- PresidentRamin Najafi Oct 24, 2007 to Oct 24, 200717
- Chief financial officerTommy Law Feb 24, 2023 to now19
- Chief financial officerAndrew D. Jones May 13, 2020 to Feb 17, 202320
- Chief financial officerJason Philip Raleigh Mar 26, 2019 to Oct 28, 201921
- Chief financial officerJohn Joseph McGovern Aug 1, 2017 to Oct 11, 201822
- Chief financial officerJohn James O'Reilly Oct 24, 2007 to Dec 18, 200723
- Chief operating officerHenry Blynn Jul 24, 2026 to now24
Board members and other officers (32)
- Chief Product OfficerAudrey Kunin Nov 17, 2021 to Dec 7, 202225
- NEO - Sr Mgr and ControllerWang Xu Mar 19, 2020 to Aug 24, 202026
- Chief Commercial OfficerLewis J. Stuart Jan 8, 2018 to Jan 8, 201827
- Senior Vice PresidentRussell A. Hoon Dec 24, 2014 to Apr 30, 201528
- SVP Product DevelopmentKeith R. Bley Mar 6, 2013 to Sep 30, 201429
- SVP, Ophthalmic Product Devt.David W. Stroman Oct 5, 2011 to Oct 6, 201530
- SVP Bus & Corp DevelopmentRoy J. Wu Sep 8, 2009 to Oct 6, 201531
- SVP Business and Corporate DevJohn James O'Reilly Sep 9, 2008 to Feb 1, 201132
- VP, Research & Dev'tBehzad Khosrovi Oct 24, 2007 to Jan 14, 201333
- VP, Clinical Research & Dev'tColin Scott Oct 24, 2007 to Feb 1, 201134
- Board memberDavid Garcia Rios Sep 8, 2026 to now35
- Board memberDavid E. Lazar Aug 26, 2025 to now13
- Board memberMichael John Kazley Oct 20, 2025 to now14
- Board memberJulie Garlikov Feb 3, 2022 to May 30, 202436
- Board memberYongxiang Zheng Feb 10, 2022 to May 30, 202437
- Board memberAudrey Kunin Sep 16, 2022 to Nov 23, 202238
- Board memberSwan Sit Jan 28, 2020 to now39
- Board memberYenyou Zheng Sep 30, 2019 to now40
- Board memberXiaopei Wang Dec 18, 2019 to May 29, 202041
- Board memberXinzhou Li Jul 7, 2017 to May 25, 202142
- Board memberMijia Wu Feb 1, 2016 to May 30, 202443
- Board memberTodd Erik Zavodnick May 10, 2016 to Oct 30, 201944
- Board memberMark M. Sieczkarek Jan 9, 2014 to Oct 28, 201945
- Board memberMassimo Radaelli Jan 9, 2014 to Jan 6, 201646
- Board memberGail J. Maderis Oct 8, 2010 to Oct 28, 201947
- Board memberHarry F. Hixson Jr. Jan 16, 2009 to Jan 5, 201048
- Board memberAnthony Dailley Oct 24, 2007 to Mar 21, 201449
- Board memberCharles Cashion Oct 24, 2007 to Jan 6, 201550
- Board memberJohn James O'Reilly Oct 24, 2007 to Feb 1, 201123
- Board memberRamin Najafi Oct 24, 2007 to Aug 21, 201517
- Board memberRobert R. Tufts Oct 24, 2007 to Jan 31, 201451
- Board memberTony D.s. Wicks Oct 24, 2007 to Jan 6, 201552
Named in SEC Form D filings
People the company listed in its private-offering notices.
Former names
- NovaBay Pharmaceuticals, Inc.Feb 14, 2007 to Mar 23, 20262
Timeline
- Oct 20, 2025New chief executive Michael John Kazley becomes CEO14
- Aug 26, 2025New chief executive David E. Lazar becomes CEO13
- Oct 11, 2018New chief executive John Joseph McGovern becomes CEO15
- Jun 8, 2016New chief executive Mark M. Sieczkarek becomes CEO16
- Oct 24, 2007New chief executive Ramin Najafi becomes CEO17
Filings
360 filings to the SEC since October 2021: 8 annual reports, 15 quarterly reports, 76 major events, 93 insider forms, 37 large holders, 8 private raises, 123 other. The latest 20:
- Oct 6, 2026S-3/A EDGAR
- Oct 5, 20268-K EDGAR
- Sep 29, 20268-K EDGAR
- Sep 28, 2026DEF 14A EDGAR
- Sep 16, 2026S-3/A EDGAR
- Sep 8, 20263 EDGAR
- Sep 8, 20268-K EDGAR
- Aug 21, 2026SCHEDULE 13D/A EDGAR
- Aug 17, 2026SCHEDULE 13G/A EDGAR
- Aug 11, 2026S-3 EDGAR
- Jul 31, 20268-K EDGAR
- Jul 30, 202610-Q EDGAR
- Jul 24, 2026SCHEDULE 13D/A EDGAR
- Jul 24, 2026SCHEDULE 13D/A EDGAR
- Jul 24, 20263 EDGAR
- Jul 22, 2026SCHEDULE 13D/A EDGAR
- Jul 17, 20268-K EDGAR
- Jun 17, 20264 EDGAR
- Jun 17, 20264 EDGAR
- Jun 17, 20264 EDGAR
The 360 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
62 open-market trades by officers, directors and large owners since October 2021: 51 buys and 11 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Kazley Michael JohnChief Executive Officer | Sale | 24,720 | $1.09 | $26.9K | Form 4 |
| Jun 15, 2026 | Framework Ventures Management LLC10% owner | Sale | 24,720 | $1.09 | $26.9K | Form 4 |
| Jun 15, 2026 | R01 Capital Manager LLC10% owner | Sale | 24,720 | $1.09 | $26.9K | Form 4 |
| Apr 8, 2025 | FAKHRY JAD10% owner | Buy | 300 | $0.47 | $141 | Form 4 |
| Apr 4, 2025 | FAKHRY JAD10% owner | Buy | 4,538 | $0.52 | $2.4K | Form 4 |
| Apr 3, 2025 | FAKHRY JAD10% owner | Buy | 22,976 | $0.56 | $12.9K | Form 4 |
| Apr 2, 2025 | FAKHRY JAD10% owner | Buy | 917 | $0.58 | $532 | Form 4 |
| Apr 1, 2025 | POPLAR POINT CAPITAL PARTNERS LP10% owner | Buy | 19,915 | $0.59 | $11.8K | Form 4 |
| Mar 31, 2025 | POPLAR POINT CAPITAL PARTNERS LP10% owner | Buy | 21,654 | $0.59 | $12.8K | Form 4 |
| Mar 28, 2025 | POPLAR POINT CAPITAL PARTNERS LP10% owner | Buy | 49,400 | $0.61 | $30.1K | Form 4 |
| Mar 27, 2025 | POPLAR POINT CAPITAL PARTNERS LP10% owner | Buy | 19,104 | $0.62 | $11.8K | Form 4 |
| Mar 26, 2025 | POPLAR POINT CAPITAL PARTNERS LP10% owner | Buy | 13,292 | $0.61 | $8.1K | Form 4 |
| Mar 25, 2025 | FAKHRY JAD10% owner | Buy | 22,635 | $0.61 | $13.8K | Form 4 |
| Mar 24, 2025 | FAKHRY JAD10% owner | Buy | 100 | $0.61 | $61 | Form 4 |
| Mar 21, 2025 | FAKHRY JAD10% owner | Buy | 6,372 | $0.61 | $3.9K | Form 4 |
| Mar 20, 2025 | FAKHRY JAD10% owner | Buy | 5,320 | $0.61 | $3.2K | Form 4 |
| Mar 19, 2025 | FAKHRY JAD10% owner | Buy | 1,500 | $0.60 | $900 | Form 4 |
| Mar 18, 2025 | FAKHRY JAD10% owner | Buy | 14,000 | $0.63 | $8.8K | Form 4 |
| Mar 18, 2025 | POPLAR POINT CAPITAL GP LLC10% owner | Buy | 10,000 | $0.63 | $6.3K | Form 4 |
| Mar 14, 2025 | POPLAR POINT CAPITAL GP LLC10% owner | Buy | 25,511 | $0.63 | $16.1K | Form 4 |
All 62 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Sky Frontier FoundationSCHEDULE 13D/A, 3 filings May 27, 2026 to Aug 21, 202654
- Tether Global Investments Fund, S.I.C.A.F., S.A.SCHEDULE 13G/A, 2 filings May 22, 2026 to Aug 17, 202655
- Framework Ventures IV L.P.SCHEDULE 13D/A, 7 filings Oct 15, 2025 to Jul 24, 202656
- R01 Fund LPSCHEDULE 13D/A, 8 filings Oct 15, 2025 to Jul 24, 202657
- POPLAR POINT CAPITAL MANAGEMENT LLCSCHEDULE 13D/A, 7 filings Jan 10, 2025 to Mar 11, 202658
- David E. LazarSCHEDULE 13D/A, 3 filings Aug 26, 2025 to Jan 29, 202659
- Hudson Bay Capital Management LPSC 13G/A, 4 filings Feb 4, 2022 to Nov 8, 202460
- ARMISTICE CAPITAL, LLCSC 13G/A, 2 filings Feb 14, 2023 to Feb 14, 202461
- Altium Capital Management LLCSC 13G/A, 1 filing Feb 13, 202462
Money raised
Private offerings the company reported to the SEC on Form D.
- Jan 16, 2026Raised $134 million in a private offering of securities Form D: 4 investors so far Form D
- Jun 14, 2024Raised $225,953 in a private offering of securities Form D: 5 investors so far Form D
- Mar 24, 2024Raised $665,000 in a private offering of debt Form D: 5 investors so far Form D
- Dec 21, 2023Raised $554,808 in a private offering of securities Form D: 5 investors so far Form D
- May 1, 2023Raised $3 million in a private offering of debt Form D: 5 investors so far Form D
- Sep 23, 2022Raised $3.2 million in a private offering of equity Form D: 4 investors so far Form D
- Sep 9, 2022Raised $2.1 million in a private offering of equity Form D: 9 investors so far Form D
- Nov 2, 2021Raised $15 million in a private offering of equity Form D: 7 investors so far Form D
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 424,695 | $445.9K | 0.0% | +1,352 |
| Vanguard Capital Management LLC | 326,988 | $343.3K | 0.0% | +54,831 |
| Geode Capital Management, LLC | 281,483 | $295.7K | 0.0% | −8,786 |
| Vanguard Fiduciary Trust Co | 131,840 | $138.4K | 0.0% | +1,056 |
| State Street Corp | 117,154 | $123.0K | 0.0% | No change |
| Northern Trust Corp | 59,926 | $62.9K | 0.0% | +6,250 |
| Bank of New York Mellon Corp | 28,033 | $29.4K | 0.0% | New |
| Renaissance Technologies LLC | 26,142 | $27.4K | 0.0% | −56,653 |
| State of Wyoming | 23,509 | $24.7K | 0.0% | −789 |
| Jane Street Group, LLC | 22,639 | $23.8K | 0.0% | −98,465 |
| Two Sigma Investments, LP | 12,396 | $13.0K | 0.0% | −12,399 |
| Vanguard Global Advisers, LLC | 11,414 | $12.0K | 0.0% | No change |
| Tower Research Capital LLC (TRC) | 8,571 | $9.0K | 0.0% | +6,423 |
| SBI Securities Co., Ltd. | 406 | $426 | 0.0% | New |
| UBS Group AG | 205 | $215 | 0.0% | +202 |
| Morgan Stanley | 3 | $3 | 0.0% | No change |
| Nvwm, LLC | 1 | $1 | 0.0% | No change |
| Caitong International Asset Management Co., Ltd | 1 | $1 | 0.0% | New |
| Farther Finance Advisors, LLC | 1 | $1 | 0.0% | New |
| Mosley Wealth Management | 1 | $1 | 0.0% | New |
| Fmr LLC | 0 | $0 | 0.0% | −3 |
| Royal Bank Of Canada | 1 | $0 | 0.0% | No change |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18SEC EDGARJeffrey Kunin, President
- 19SEC EDGARTommy Law, Chief financial officer
- 20
- 21
- 22
- 23
- 24SEC EDGARHenry Blynn, Chief operating officer
- 25SEC EDGARAudrey Kunin, Chief Product Officer
- 26SEC EDGARWang Xu, NEO - Sr Mgr and Controller
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35SEC EDGARDavid Garcia Rios, Board member
- 36SEC EDGARJulie Garlikov, Board member
- 37SEC EDGARYongxiang Zheng, Board member
- 38SEC EDGARAudrey Kunin, Board member
- 39SEC EDGARSwan Sit, Board member
- 40SEC EDGARYenyou Zheng, Board member
- 41SEC EDGARXiaopei Wang, Board member
- 42SEC EDGARXinzhou Li, Board member
- 43SEC EDGARMijia Wu, Board member
- 44SEC EDGARTodd Erik Zavodnick, Board member
- 45SEC EDGARMark M. Sieczkarek, Board member
- 46SEC EDGARMassimo Radaelli, Board member
- 47SEC EDGARGail J. Maderis, Board member
- 48SEC EDGARHarry F. Hixson Jr., Board member
- 49SEC EDGARAnthony Dailley, Board member
- 50SEC EDGARCharles Cashion, Board member
- 51SEC EDGARRobert R. Tufts, Board member
- 52SEC EDGARTony D.s. Wicks, Board member
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62